FRM
Fox Run Management’s Axsome Therapeutics AXSM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,584
| Closed | -$1.58M | – | 865 |
|
|
2025
Q1 | $1.58M | Buy |
13,584
+7,465
| +122% | +$871K | 0.25% | 69 |
|
|
2024
Q4 | $518K | Buy |
+6,119
| New | +$518K | 0.09% | 427 |
|
|
2023
Q4 | – | Sell |
-5,250
| Closed | -$367K | – | 731 |
|
|
2023
Q3 | $367K | Buy |
+5,250
| New | +$367K | 0.11% | 365 |
|
|
2023
Q1 | – | Sell |
-3,416
| Closed | -$263K | – | 653 |
|
|
2022
Q4 | $263K | Sell |
3,416
-2,451
| -42% | -$189K | 0.11% | 389 |
|
|
2022
Q3 | $262K | Buy |
+5,867
| New | +$262K | 0.1% | 396 |
|
|
2021
Q2 | – | Sell |
-3,797
| Closed | -$215K | – | 341 |
|
|
2021
Q1 | $215K | Buy |
+3,797
| New | +$215K | 0.39% | 158 |
|